1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GSK plc
  6. Financials
    GSK   GB00BN7SWP63

GSK PLC

(GSK)
  Report
Delayed London Stock Exchange  -  11:35 2022-08-05 am EDT
1667.00 GBX   +0.52%
08/05UK Financial Watchdog Fines Ex-ConvaTec Chair For Sharing Inside Information
MT
08/05GSK : Morgan stanley resumes coverage with equal weight; target p…
RE
08/03European ADRs Nudge Higher in Wednesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 88 05166 80180 45867 485--
Enterprise Value (EV)1 113 77387 581100 29683 33179 44377 708
P/E ratio 19,2x11,8x18,6x15,4x13,3x12,9x
Yield 4,50%5,96%4,98%3,43%3,43%3,48%
Capitalization / Revenue 2,61x1,96x2,36x2,25x2,21x2,10x
EV / Revenue 3,37x2,57x2,94x2,78x2,61x2,42x
EV / EBITDA 9,51x9,19x8,85x9,04x8,09x7,53x
Price to Book 7,35x4,58x5,34x4,32x4,00x3,44x
Nbr of stocks (in thousands) 3 959 5723 982 1854 006 3834 048 313--
Reference price (GBP) 22,216,820,116,716,716,7
Announcement Date 02/05/202002/03/202102/09/2022---
1 GBP in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 33 75434 09934 11429 99230 49632 165
EBITDA1 11 9689 53011 3309 2159 81910 325
Operating profit (EBIT)1 8 9728 9068 8067 9598 5939 251
Operating Margin 26,6%26,1%25,8%26,5%28,2%28,8%
Pre-Tax Profit (EBT)1 6 2216 9685 4426 1306 6547 375
Net income1 4 6455 7494 3854 4105 0355 280
Net margin 13,8%16,9%12,9%14,7%16,5%16,4%
EPS2 1,161,431,081,091,251,29
Dividend per Share2 1,001,001,000,570,570,58
Announcement Date 02/05/202002/03/202102/09/2022---
1 GBP in Million
2 GBP
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales1 9 5279 7806 9297 2897 0035 865
EBITDA1 2 4063 3172 6392 5341 745-
Operating profit (EBIT)1 1 8932 6132 0082 3231 7991 761
Operating Margin 19,9%26,7%29,0%31,9%25,7%30,0%
Pre-Tax Profit (EBT) 7062 598896---
Net income1 7491 8029751 263665-
Net margin 7,86%18,4%14,1%17,3%9,49%-
EPS2 0,180,450,210,320,19-
Dividend per Share ------
Announcement Date 02/09/202204/27/202207/27/2022---
1 GBP in Million
2 GBP
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 25 72220 78019 83815 84611 95810 223
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,15x2,18x1,75x1,72x1,22x0,99x
Free Cash Flow1 5 0735 4064 4375 0995 1966 146
ROE (Net Profit / Equities) 75,0%44,4%38,2%37,9%45,2%41,0%
Shareholders' equity1 6 19112 95111 47211 63411 14012 868
ROA (Net Profit / Asset) 8,90%7,18%5,50%6,98%7,45%8,15%
Assets1 52 18580 06279 76863 15967 57364 787
Book Value Per Share2 3,023,663,763,864,174,84
Cash Flow per Share2 2,002,091,961,461,621,87
Capex1 1 2651 2261 1721 1591 2811 315
Capex / Sales 3,75%3,60%3,44%3,86%4,20%4,09%
Announcement Date 02/05/202002/03/202102/09/2022---
1 GBP in Million
2 GBP
Previous periodNext period
Estimates
Key data
Capitalization (GBP) 67 485 379 910
Capitalization (USD) 81 285 161 835
Net sales (GBP) 34 114 000 000
Net sales (USD) 41 089 818 484
Number of employees 90 096
Sales / Employee (GBP) 378 641
Sales / Employee (USD) 456 067
Free-Float 93,6%
Free-Float capitalization (GBP) 63 175 289 118
Free-Float capitalization (USD) 76 093 719 955
Avg. Exchange 20 sessions (GBP) 13 163 858 189
Avg. Exchange 20 sessions (USD) 15 855 676 365
Average Daily Capital Traded 19,5%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA